Home » Thought Leadership

Thought Leadership

Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.

Showing 5 of 139 posts
Regulators and HTA Bodies
August 24, 2021 | Blogs, Infographics

Drug Assessment Uncertainties: HTA Bodies vs. Regulators

A recent study of the review of new medicines by regulatory and HTA bodies has revealed areas of misalignment in their processes, highlighting unique challenges in the pathway to patient access.

Cover Image for NRDL Market Access Rare Disease Therapies China 2020 NRDL
August 19, 2021 | Blogs

What Market Access Opportunities Exist for Rare Disease Products in China? An Analysis of Rare Disease Product Inclusion in the 2020 NRDL

The first of two articles investigating market access opportunities in China - CBPartners’ Asia-Pacific Center of Excellence analyzes the opportunities that lie ahead for rare disease products based on 2020 NRDL update inclusion.

August 5, 2021 | Culture Blog, News

CBPartners’ Healthcare Career Exposure Partnership with Local Civics

CBPartners collaborated with the Local Civics team to create a series of workshops as part of a ‘Healthcare Career Exposure’ in order to expose a diverse cross-section of NYC high school students to alternative careers within the healthcare space.

CMS Hospital Pricing Transparency
August 2, 2021 | Blogs

CMS Hospital Pricing Transparency: One Price Fits All?

A CMS regulation from the Trump Administration requires hospitals to post lists containing the list price, negotiated private payer prices, and self-pay rates for up to 300 shoppable services took effect in January 2021, with the rule still being widely ignored by hospitals.

CBPartners' Pharma Take-Away: AMARIN's VASCEPA patent loss: is it obvious(ness)?
July 20, 2021 | Podcasts

Trends and Dynamics of the Biosimilar Market across the EU, Latin America and Asia Pacific Regions

The biosimilar market is booming across the EU, Latin America and Asia Pacific regions. In this next episode of the multi-part biosimilar series, CBPartners’ regional Centers of Excellence teams provide expert insights into the trends and dynamics of the biosimilar market, with a particular focus on these regions.